Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.036 | 0.8 |
mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |